Share-based Payment Arrangement, Expense in USD of WINDTREE THERAPEUTICS INC /DE/ from 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
WINDTREE THERAPEUTICS INC /DE/ quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2010 to Q3 2025.
  • WINDTREE THERAPEUTICS INC /DE/ Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $17K, a 80.2% decline year-over-year.
  • WINDTREE THERAPEUTICS INC /DE/ Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $141K, a 80.9% decline year-over-year.
  • WINDTREE THERAPEUTICS INC /DE/ annual Share-based Payment Arrangement, Expense for 2024 was $455K, a 64.4% decline from 2023.
  • WINDTREE THERAPEUTICS INC /DE/ annual Share-based Payment Arrangement, Expense for 2023 was $1.28M, a 58.6% decline from 2022.
  • WINDTREE THERAPEUTICS INC /DE/ annual Share-based Payment Arrangement, Expense for 2022 was $3.09M, a 57.4% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

WINDTREE THERAPEUTICS INC /DE/ Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $141K $17K -$69K -80.2% 01 Jul 2025 30 Sep 2025 10-Q 19 Nov 2025
Q2 2025 $210K $31K -$66K -68% 01 Apr 2025 30 Jun 2025 10-Q 19 Aug 2025
Q1 2025 $276K $72K -$179K -71.3% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 $455K $21K -$285K -93.1% 01 Oct 2024 31 Dec 2024 10-K 15 Apr 2025
Q3 2024 $740K $86K -$219K -71.8% 01 Jul 2024 30 Sep 2024 10-Q 19 Nov 2025
Q2 2024 $959K $97K -$285K -74.6% 01 Apr 2024 30 Jun 2024 10-Q 19 Aug 2025
Q1 2024 $1.24M $251K -$34K -11.9% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 $1.28M $306K -$485K -61.3% 01 Oct 2023 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 $1.76M $305K -$439K -59% 01 Jul 2023 30 Sep 2023 10-Q 26 Nov 2024
Q2 2023 $2.2M $382K -$399K -51.1% 01 Apr 2023 30 Jun 2023 10-Q 19 Aug 2024
Q1 2023 $2.6M $285K -$485K -63% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 $3.09M $791K -$831K -51.2% 01 Oct 2022 31 Dec 2022 10-K 16 Apr 2024
Q3 2022 $3.92M $744K -$885K -54.3% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 $4.8M $781K -$763K -49.4% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023
Q1 2022 $5.57M $770K -$1.67M -68.5% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 $7.24M $1.62M +$341K +26.6% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 $6.9M $1.63M +$481K +41.9% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 $6.42M $1.54M -$22K -1.41% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 $6.44M $2.44M +$754K +44.6% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q4 2020 $5.68M $1.28M -$232K -15.3% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 $5.92M $1.15M -$791K -40.8% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 $6.71M $1.57M -$173K -9.95% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021
Q1 2020 $6.88M $1.69M +$159K +10.4% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 $6.72M $1.51M +$1.26M +500% 01 Oct 2019 31 Dec 2019 10-K 29 Mar 2021
Q3 2019 $5.46M $1.94M +$1.79M +1237% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020
Q2 2019 $3.67M $1.74M +$1.6M +1142% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020
Q1 2019 $2.07M $1.53M +$1.11M +266% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020
Q4 2018 $955K $252K -$577K -69.6% 01 Oct 2018 31 Dec 2018 10-K 03 Apr 2020
Q3 2018 $1.53M $145K -$33K -18.5% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 $1.57M $140K -$114K -44.9% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019
Q1 2018 $1.68M $418K +$118K +39.3% 01 Jan 2018 31 Mar 2018 10-Q 20 May 2019
Q4 2017 $1.56M $829K +$532K +179% 01 Oct 2017 31 Dec 2017 10-K/A 23 Apr 2019
Q3 2017 $1.03M $178K -$95K -34.8% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 $1.12M $254K +$4K +1.6% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018
Q1 2017 $1.12M $300K -$303K -50.2% 01 Jan 2017 31 Mar 2017 10-Q 21 May 2018
Q4 2016 $1.42M $297K -$47K -13.7% 01 Oct 2016 31 Dec 2016 10-K 17 Apr 2018
Q3 2016 $1.47M $273K -$145K -34.7% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q2 2016 $1.62M $250K -$85K -25.4% 01 Apr 2016 30 Jun 2016 10-Q 21 Aug 2017
Q1 2016 $1.7M $603K +$4K +0.67% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q4 2015 $1.7M $344K -$256K -42.7% 01 Oct 2015 31 Dec 2015 10-K 31 Mar 2017
Q3 2015 $1.95M $418K -$439K -51.2% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016
Q2 2015 $2.39M $335K -$446K -57.1% 01 Apr 2015 30 Jun 2015 10-Q 10 Aug 2016
Q1 2015 $2.84M $599K -$104K -14.8% 01 Jan 2015 31 Mar 2015 10-Q 12 May 2016
Q4 2014 $2.94M $600K -$6K -0.99% 01 Oct 2014 31 Dec 2014 10-K 29 Mar 2016
Q3 2014 $2.95M $857K +$216K +33.7% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015
Q2 2014 $2.73M $781K +$174K +28.7% 01 Apr 2014 30 Jun 2014 10-Q 10 Aug 2015
Q1 2014 $2.56M $703K +$347K +97.5% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015
Q4 2013 $2.21M $606K -$527K -46.5% 01 Oct 2013 31 Dec 2013 10-K 16 Mar 2015
Q3 2013 $2.74M $641K +$167K +35.2% 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014
Q2 2013 $2.57M $607K +$201K +49.5% 01 Apr 2013 30 Jun 2013 10-Q 07 Aug 2014
Q1 2013 $2.37M $356K -$42K -10.6% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014
Q4 2012 $2.41M $1.13M 01 Oct 2012 31 Dec 2012 10-K 16 Mar 2015
Q3 2012 $474K +$326K +220% 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013
Q2 2012 $406K +$223K +122% 01 Apr 2012 30 Jun 2012 10-Q 08 Aug 2013
Q1 2012 $398K 01 Jan 2012 31 Mar 2012 10-Q 07 May 2013
Q3 2011 $148K 01 Jul 2011 30 Sep 2011 10-Q 14 Nov 2012
Q2 2011 $183K 01 Apr 2011 30 Jun 2011 10-Q 14 Aug 2012

WINDTREE THERAPEUTICS INC /DE/ Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $455K -$823K -64.4% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025
2023 $1.28M -$1.81M -58.6% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025
2022 $3.09M -$4.15M -57.4% 01 Jan 2022 31 Dec 2022 10-K 16 Apr 2024
2021 $7.24M +$1.55M +27.3% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 $5.68M -$1.04M -15.4% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2019 $6.72M +$5.77M +604% 01 Jan 2019 31 Dec 2019 10-K 29 Mar 2021
2018 $955K -$606K -38.8% 01 Jan 2018 31 Dec 2018 10-K 03 Apr 2020
2017 $1.56M +$138K +9.7% 01 Jan 2017 31 Dec 2017 10-K/A 23 Apr 2019
2016 $1.42M -$273K -16.1% 01 Jan 2016 31 Dec 2016 10-K 17 Apr 2018
2015 $1.7M -$1.25M -42.3% 01 Jan 2015 31 Dec 2015 10-K 31 Mar 2017
2014 $2.94M +$731K +33.1% 01 Jan 2014 31 Dec 2014 10-K 29 Mar 2016
2013 $2.21M -$201K -8.34% 01 Jan 2013 31 Dec 2013 10-K 16 Mar 2015
2012 $2.41M +$1.54M +178% 01 Jan 2012 31 Dec 2012 10-K 16 Mar 2015
2011 $867K -$543K -38.5% 01 Jan 2011 31 Dec 2011 10-K 17 Mar 2014
2010 $1.41M 01 Jan 2010 31 Dec 2010 10-K 15 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.